Clinical Trials

Showing 441 - 460 of 488 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of EPZ-5676 to Treat Children with Recurrent or Persistent MLL-Mutant Acute Leukemia
Relapsed/Refractory
[Protocol 14-080]
Shukla, Neerav
A Phase I Study of EPZ-5676 in Patients with Relapsed/Refractory Leukemia and Other Advanced Hematologic Cancers
[Protocol 12-181]
Tallman, Martin
  • Hematology
    • Hematologic Malignancies
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
    • Myeloproliferative Neoplasm
A Phase I Study of Enzalutamide (MDV3100) in Patients with Previously Treated Metastatic Breast Cancer
[Protocol 12-155]
Traina, Tiffany
  • Breast Cancer
A Phase I Study of EGF816 in Patients with Lung Cancer Containing the EGFR T790M Mutation
[Protocol 14-112]
Riely, Gregory
A Phase I Study of DSTP3086S in Patients with Metastatic Castration-Resistant Prostate Cancer
[Protocol 11-016]
Danila, Daniel
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase I Study of DS-3032B in Patients with Advanced Solid Tumors or Lymphomas
[Protocol 13-171]
Gounder, Mrinal
  • Lymphoma
  • Solid Tumors
A Phase I Study of DLYE5953A in Patients with Advanced or Persistent Solid Tumors
[Protocol 14-089]
Modi, Shanu
  • Breast Cancer
  • Head & Neck Cancer
  • Lung Cancer, Non-Small Cell
  • Ovarian Cancer
  • Upper Gastrointestinal
    • Gastric Cancer
    • Pancreatic Cancer
A Phase I Study of Debio1347 in Patients with Advanced Cancers Containing FGFR Alterations
[Protocol 13-131]
Voss, Martin
  • Bladder Cancer
  • Breast Cancer
  • Head & Neck Cancer
  • Lung Cancer, Non-Small Cell
    • Other
  • Lung Cancer, Small Cell
  • Solid Tumors
  • Upper Gastrointestinal
    • Gastric Cancer
  • Uterine (Endometrial) Cancer
A Phase I Study of Dasatinib and Ipilimumab for Patients with Advanced GIST or Other Sarcomas
[Protocol 12-083]
Carvajal, Richard
A Phase I Study of Daily Low-Dose Erlotinib and Twice Weekly High-Dose Erlotinib in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
[Protocol 12-278]
Yu, Helena
  • Lung Cancer, Non-Small Cell
A Phase I Study of Dabrafenib and Ipilimumab with and without Trametinib for Advanced Melanoma
[Protocol 12-285]
Callahan, Margaret
  • Melanoma
A Phase I Study of CUDC-907 in Patients with Relapsed or Refractory Lymphoma or Multiple Myeloma
Relapsed/Refractory
[Protocol 13-045]
Younes, Anas
  • Hematology
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of CPI-0610 in Patients with Progressive Lymphoma
Relapsed/Refractory
[Protocol 13-259]
Younes, Anas
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase I Study of Convection-Enhanced Delivery of 124I-8H9 for Patients with Non-Progressive Diffuse Pontine Gliomas Previously Treated with Radiation Therapy
[Protocol 11-011]
Souweidane, Mark
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of Consolidation Therapy with Autologous T Cells Genetically Targeted to CD19 in Patients with Chronic Lymphocytic Leukemia After Initial Chemotherapy
[Protocol 11-048]
Park, Jae
A Phase I Study of Certolizumab plus Chemotherapy for Patients with Stage IV Lung Adenocarcinoma
[Protocol 13-063]
Paik, Paul
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of CB-839 in Patients with Advanced Solid Tumors
[Protocol 14-111]
Harding, James
  • Breast Cancer
  • Colorectal Cancer
  • Head & Neck Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Melanoma
  • Mesothelioma
  • Solid Tumors
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase I Study of CB-839 in Patients with Advanced or Persistent Hematologic Cancers
[Protocol 14-053]
Younes, Anas
  • Hematology
    • Hematologic Malignancies
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of Carfilzomib in Patients with Previously Treated Systemic Light Chain Amyloidosis
[Protocol 12-276]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase I Study of Carboxyamidotriazole Orotate Plus Temozolomide in Patients with Glioblastoma Multiforme and Other Recurrent Malignant Gliomas
[Protocol 12-007]
Omuro, Antonio
  • Brain Tumors, Primary
    • Gliomas